Seeking Alpha

Galena Biopharma (GALE) files a registration statement (S-3) with the SEC to sell up to 9.47M...

Galena Biopharma (GALE) files a registration statement (S-3) with the SEC to sell up to 9.47M shares of its common stock on behalf of shareholders. If completed in full, the offering represents 18.8% of all outstanding shares.
From other sites
Comments (3)
  • Broader
    , contributor
    Comment (1) | Send Message
     
    Individual investor with 15 year's experience in the market: I still can't tell the future.

     

    Are these treasury shares that Galena proposes to share?
    12 Apr 2012, 07:30 AM Reply Like
  • Christopher Wallace
    , contributor
    Comments (1133) | Send Message
     
    No, this is a registration of the intention of insiders to sell shares which they presently own.
    12 Apr 2012, 02:02 PM Reply Like
  • Ron Reed
    , contributor
    Comments (295) | Send Message
     
    Capital building for PHIII testing.
    14 May 2012, 10:27 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs